A recent discussion highlights the potential link between regular ibuprofen use and hearing loss. Dr. Martin Scurr references the Nurses' Health St...
Nucleus RadioPharma has appointed Dr. Stephen Hahn, former FDA commissioner, as its new CEO. Nucleus, a company focused on radiopharmaceuticals, ai...
Recent research has focused on the treatment of asciminib-resistant chronic myeloid leukemia (CML) using a combination of venetoclax and ponatinib....
Spending on diabetes medications in NHS England has increased by 18% over the past year, now accounting for 15% of all prescription spending. The r...
Scribe Therapeutics, a genetic medicines company, is set to participate in several major medical, scientific, and investor conferences throughout S...
ECOlab has expanded its production capabilities in the Moscow region by opening a new workshop in Elektrogorsk, with an investment of 500 million r...
Argenx, a Netherlands-based pharmaceutical company, has announced positive results from its ADAPT SERON trial for Vyvgart (efgartigimod), a treatme...
Argenx, a Netherlands-based pharmaceutical company, has released positive results from its ADAPT SERON trial for Vyvgart (efgartigimod), a drug des...
The European Union has introduced the Health Technology Assessment Regulation (HTAR), effective January 2025, which includes the Joint Clinical Ass...
Serena Williams, a renowned tennis champion, has publicly discussed her use of weight loss drugs to address the stigma surrounding such medications...